Drug intelligence / Profile preview

acetaminophen + gamma-aminobutyric acid + codeine phosphate

Development stage
Approved
Lead developer
Physician Therapeutics
Modality
Small Molecules
Administration
Oral
01

Overview

Acetaminophen + gamma-aminobutyric acid + codeine phosphate is an oral combination product marketed as **Theracodeine-300**, a convenience kit that combines acetaminophen and codeine phosphate tablets with the medical food Theramine, which contains gamma-aminobutyric acid as part of a proprietary amino acid blend. The analgesic effect is driven primarily by acetaminophen, a centrally acting non-opioid analgesic and antipyretic, together with codeine phosphate, an opioid analgesic whose active metabolite engages mu-opioid receptors to reduce pain perception. The gamma-aminobutyric acid component is included via the Theramine medical food for dietary management of pain and inflammatory conditions rather than as a conventional approved analgesic active pharmaceutical ingredient. The product is intended for the relief of mild to moderately severe pain and is associated with the known opioid risks of codeine, including respiratory depression, misuse, and dependence potential.

Brand names
Theracodeine-300Theracodeine300Theracodeine 300
Other names
acetaminophen + gamma-aminobutyric acid + codeine phosphateacetaminophen and codeine phosphate tablets + Theramine
02

Targets

GABRR (GABA-A receptor subunit rho)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on acetaminophen + gamma-aminobutyric acid + codeine phosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetaminophen + gamma-aminobutyric acid + codeine phosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call